WebPage 1/8 Safety Data Sheet acc. to OSHA HCS Printing date 02/25/2024 Revision date 02/25/2024 53.1.21 * 1 Identification · Product identifier · Trade name:Irinotecan (hydrochloride hydrate) · Article number:14180 · CAS Number: 100286-90-6 · EC number: 600-054-0 · Application of the substance / the mixture This product is for research use - … WebFor general information or questions, call 855-960-0578. For appointments, contact your preferred doctor or location directly. For doctor- or location- specific contact information, …
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
WebMay 1, 2024 · Irinotecan hydrochloride injection must be diluted prior to infusion using aseptic technique. Irinotecan hydrochloride injection should be diluted in 5% Dextrose Injection, USP, (preferred) or 0.9% Sodium Chloride Injection, USP, to a final concentration range of 0.12 mg/mL to 2.8 mg/mL. WebIrinotecan Safety Data Sheet according to the REACH Regulation (EC) 1907/2006 amended by Regulation (EU) 2024/878 03/04/2024 (Issue date) EN (English) 3/8 5.3. Advice for firefighters Firefighting instructions : Use extinguishing media appropriate for surrounding fire. SECTION 6: Accidental release measures 6.1. iprofile free
Irinotecan (Camptosar) UPMC Hillman Cancer Center
WebONIVYDE® (irinotecan liposome injection) is indicated, in combination with fluorouracil (5-FU) and leucovorin (LV), for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression … WebJun 29, 2024 · You have to go to the hospital for radiotherapy as an outpatient daily from Monday to Friday for 5 weeks. In group 2, you also have irinotecan at the hospital once a week for 4 weeks. This takes an hour. You have a CT scan at 4 weeks then at 1, 2 and 3 years after finishing your chemoradiotherapy. WebThis page contains brief information about irinotecan hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical … orc or undead warlock